Sanofi S.r.l. NDCs and Package Codes
This page lists NDC package records associated with labeler code 12522 (Sanofi S.r.l.) — including active listings, ingredients, drug names, strengths, dosage forms, package sizes, pricing data when available, and links to each individual NDC page.
Key stats
4
Package NDCs
3
Products
3
Active listings
0
Discontinued
3
Ingredients
0
Therapeutic classes
3
Dosage forms
0
With NADAC pricing
Portfolio
Top ingredients
By dosage form
Browse records — 3 products
| Drug / product | Billing NDC | NADAC / unit | Status | |
|---|---|---|---|---|
| belumosudil 200 mg/1 TABLET | 12522-3310-06 | — | On market | View → |
| IMIGLUCERASE 40 U/mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 12522-7100-01 | — | On market | View → |
| rilzabrutinib 400 mg/1 TABLET, FILM COATED | 12522-3331-02 | — | On market | View → |
Where does this data come from?
NDC package records, ingredients, strengths and forms come from the openFDA NDC Directory, grouped by the 5-digit labeler code; pricing is CMS NADAC. This is a factual data directory, not a manufacturer marketing page.